J Del Rosso

Summary

Publications

  1. ncbi request reprint Journal of Drugs in Dermatology: New methods and Techniques. Managing acne with adapalene 0.1% and 0.3% gels. Introduction
    James Q Del Rosso
    J Drugs Dermatol 7:s2. 2008
  2. ncbi request reprint Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 4: a status report on physical modalities and devices
    Emil Tanghetti
    Cutis 93:71-6. 2014
  3. ncbi request reprint Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies
    James Q Del Rosso
    Cutis 93:18-28. 2014
  4. ncbi request reprint Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care
    James Q Del Rosso
    Cutis 92:234-40. 2013
  5. ncbi request reprint The integration of physiologically-targeted skin care in the management of atopic dermatitis: focus on the use of a cleanser and moisturizer system incorporating a ceramide precursor, filaggrin degradation products, and specific "skin-barrier-friendly" ex
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, NV, USA
    J Drugs Dermatol 12:s85-91. 2013
  6. doi request reprint Management of facial erythema of rosacea: what is the role of topical α-adrenergic receptor agonist therapy?
    James Q Del Rosso
    Dermatology Residency Program, Valley Hospital Medical Center Las Vegas, Las Vegas, Nevada Dermatology, Touro University College of Osteopathic Medicine, Henderson, Nevada Dermatology and Cutaneous Surgery, Las Vegas Skin and Cancer Clinics, Las Vegas and Henderson, Nevada Electronic address
    J Am Acad Dermatol 69:S44-56. 2013
  7. ncbi request reprint Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, NV, USA
    J Drugs Dermatol 12:626-31. 2013
  8. ncbi request reprint A status report on topical tazarotene in the management of acne vulgaris
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, NV, USA
    J Drugs Dermatol 12:s53-8. 2013
  9. ncbi request reprint Why is rosacea considered to be an inflammatory disorder? The primary role, clinical relevance, and therapeutic correlations of abnormal innate immune response in rosacea-prone skin
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, NV, USA
    J Drugs Dermatol 11:694-700. 2012
  10. ncbi request reprint Trolamine-containing topical emulsion: clinical applications in dermatology
    James Q Del Rosso
    Dermatology Residency Program, Valley Hospital Medical Center, Las Vegas, Nevada, USA
    Cutis 81:209-14. 2008

Detail Information

Publications79

  1. ncbi request reprint Journal of Drugs in Dermatology: New methods and Techniques. Managing acne with adapalene 0.1% and 0.3% gels. Introduction
    James Q Del Rosso
    J Drugs Dermatol 7:s2. 2008
  2. ncbi request reprint Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 4: a status report on physical modalities and devices
    Emil Tanghetti
    Cutis 93:71-6. 2014
    ..Rosacea-associated symptoms also may improve. In most cases, treatment will need to be repeated intermittently to sustain improvement. ..
  3. ncbi request reprint Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies
    James Q Del Rosso
    Cutis 93:18-28. 2014
    ..Other non-FDA-approved oral agents also are discussed including other tetracyclines, macrolides, metronidazole, and isotretinoin. ..
  4. ncbi request reprint Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care
    James Q Del Rosso
    Cutis 92:234-40. 2013
    ..Part 1 of this 5-part series discusses the rosacea disease state with an emphasis on clinical correlation, reviews adjunctive skin care for cutaneous rosacea, and provides management caveats. ..
  5. ncbi request reprint The integration of physiologically-targeted skin care in the management of atopic dermatitis: focus on the use of a cleanser and moisturizer system incorporating a ceramide precursor, filaggrin degradation products, and specific "skin-barrier-friendly" ex
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, NV, USA
    J Drugs Dermatol 12:s85-91. 2013
    ....
  6. doi request reprint Management of facial erythema of rosacea: what is the role of topical α-adrenergic receptor agonist therapy?
    James Q Del Rosso
    Dermatology Residency Program, Valley Hospital Medical Center Las Vegas, Las Vegas, Nevada Dermatology, Touro University College of Osteopathic Medicine, Henderson, Nevada Dermatology and Cutaneous Surgery, Las Vegas Skin and Cancer Clinics, Las Vegas and Henderson, Nevada Electronic address
    J Am Acad Dermatol 69:S44-56. 2013
    ..This article focuses on the clinical differentiation of facial erythema of rosacea and its management. ..
  7. ncbi request reprint Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, NV, USA
    J Drugs Dermatol 12:626-31. 2013
    ..Strategies to mitigate the altered effects of epidermal barrier functions are reviewed including the importance of topical barrier repair therapy...
  8. ncbi request reprint A status report on topical tazarotene in the management of acne vulgaris
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, NV, USA
    J Drugs Dermatol 12:s53-8. 2013
    ....
  9. ncbi request reprint Why is rosacea considered to be an inflammatory disorder? The primary role, clinical relevance, and therapeutic correlations of abnormal innate immune response in rosacea-prone skin
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, NV, USA
    J Drugs Dermatol 11:694-700. 2012
    ..Available therapies for rosacea exhibit reported modes of action that appear to correlate with the inhibition of inflammatory processes involved in the pathophysiology of at least some presentations of rosacea...
  10. ncbi request reprint Trolamine-containing topical emulsion: clinical applications in dermatology
    James Q Del Rosso
    Dermatology Residency Program, Valley Hospital Medical Center, Las Vegas, Nevada, USA
    Cutis 81:209-14. 2008
    ..This article reviews the mechanism of action and information on clinical applications of trolamine-containing topical emulsion...
  11. doi request reprint Oral antibiotic drug interactions of clinical significance to dermatologists
    James Q Del Rosso
    Valley Hospital Medical Center, 620 Shadow Lane, Las Vegas, NV 89106, USA
    Dermatol Clin 27:91-4. 2009
    ..Rifampin increases the metabolism of many other drugs, thus predisposing to treatment failure. Drug interactions can only be averted if their potential is understood and recognized in advance...
  12. ncbi request reprint Therapeutic experience with cefdinir in the treatment of uSSSIs
    J Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, NV, USA
    Int J Clin Pract 60:1313-6. 2006
    ..This case report briefly reviews the rationale for the use of cefdinir in the treatment of uSSSIs and presents two case studies to highlight the clinical use of this agent...
  13. doi request reprint Optimizing use of oral antibiotics in acne vulgaris
    James Q Del Rosso
    Valley Hospital Medical Center, 620 Shadow Lane, Las Vegas, NV 89106, USA
    Dermatol Clin 27:33-42. 2009
    ....
  14. ncbi request reprint Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, and Touro University College of Osteopathic Medicine, Las Vegas, NV, USA
    J Am Acad Dermatol 56:791-802. 2007
    ..Doxycycline monotherapy at antimicrobial doses has been shown to be effective for the treatment of rosacea...
  15. ncbi request reprint Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris
    James Q Del Rosso
    University of Nevada School of Medicine, Touro University College of Osteopathic Medicine, Las Vegas, NV, USA
    J Drugs Dermatol 6:616-22. 2007
    ..This 12-week study evaluated the safety and efficacy of initial topical benzoyl peroxide 5%/clindamycin 1% gel as monotherapy and in combination with adapalene gel versus adapalene gel monotherapy in the management of acne...
  16. ncbi request reprint Status report on antibiotic resistance: implications for the dermatologist
    James Q Del Rosso
    Valley Hospital Medical Center, PMB 531, 3230 E Flamingo Rad 8, Las Vegas, NV 89121, USA
    Dermatol Clin 25:127-32, v. 2007
    ..The common use of systemic antibiotic therapy in dermatology warrants a closer look at how prescribing patterns impact on the development of antibiotic resistant bacteria and outcomes in clinical practice...
  17. ncbi request reprint Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, NV 89121, USA
    J Drugs Dermatol 7:573-6. 2008
  18. ncbi request reprint American Acne & Rosacea Society rosacea medical management guidelines
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, NV 89121, USA
    J Drugs Dermatol 7:531-3. 2008
    ....
  19. ncbi request reprint A closer look at truncal acne vulgaris: prevalence, severity, and clinical significance
    James Q Del Rosso
    University of Nevada School of Medicine, Touro University College of Osteopathic Medicine Dermatology Residency Director, Valley Hospital Medical Center, Las Vegas, NV, USA
    J Drugs Dermatol 6:597-600. 2007
    ..A grading system for truncal acne vulgaris is also presented. The majority of patients presenting with truncal acne vulgaris exhibited mild to moderate severity and more than 75% were interested in treatment for truncal acne lesions...
  20. ncbi request reprint Anti-inflamatory dose doxycycline in the treatment of rosacea
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, Nevada, USA
    J Drugs Dermatol 8:664-8. 2009
    ..Additionally, a much lower incidence of gastrointestinal side effects has been noted with ADD once daily as compared to doxycycline 100 mg once daily...
  21. ncbi request reprint Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, NV 89106, USA
    J Drugs Dermatol 9:607-13. 2010
    ..Efficacy parameters revealed a possible trend toward greater and earlier benefit with the AzA-based regimen than with the metronidazole-based regimen. These findings warrant further investigation in a sufficiently powered study...
  22. doi request reprint Topical antibiotics: therapeutic value or ecologic mischief?
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, Nevada, USA
    Dermatol Ther 22:398-406. 2009
    ....
  23. doi request reprint Wound care in the dermatology office: where are we in 2011?
    James Q Del Rosso
    University of Nevada School of Medicine, Touro University College of Osteopathic Medicine, and Valley Hospital Medical Center, USA
    J Am Acad Dermatol 64:S1-7. 2011
    ....
  24. ncbi request reprint Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options
    Joseph Bikowski
    Department of Dermatology, Ohio State University, Columbus, USA
    Cutis 78:13-20. 2006
    ..Overall, these combinations appeared to be well-tolerated, effective, and, as reported in the case studies, adaptable to common clinical practice...
  25. ncbi request reprint A status report on the medical management of rosacea: focus on topical therapies
    James Q Del Rosso
    Las Vegas Skin and Cancer Clinics, Ltd, 4488 S Pecos Rd, Las Vegas, NV 89121, USA
    Cutis 70:271-5. 2002
  26. ncbi request reprint The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea
    John E Wolf
    Department of Dermatology, Baylor College of Medicine, Houston, Texas, USA
    Cutis 79:73-80. 2007
    ..The findings of this study expand the collected data on the efficacy and safety of metronidazole topical gel 0.75% beyond that demonstrated in controlled clinical trials and confirm the utility of this therapy in the community setting...
  27. ncbi request reprint Clindamycin phosphate 1.2%- tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, Nevada, USA
    Cutis 81:405-8. 2008
    ..This article reviews important vehicle characteristics of the combination gel as well as formulation stability and tolerability data that are potentially clinically relevant...
  28. ncbi request reprint Combination topical therapy in the treatment of acne
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, USA
    Cutis 78:5-12. 2006
    ..Clindamycin-benzoyl peroxide may be well-tolerated when applied with topical retinoids, creating a more targeted and complete treatment strategy...
  29. ncbi request reprint Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance
    James J Leyden
    Department of Dermatology, University of Pennsylvania, Philadelphia, USA
    Cutis 79:9-25. 2007
    ..By increasing our understanding of the multifaceted actions of antibiotics and the known clinical implications of antibiotic resistance, physicians can improve their decision making in prescribing these agents...
  30. ncbi request reprint Topical tazarotene in acne vulgaris: treatment approaches
    Dina N Anderson
    Department of Dermatology, State University of New York Downstate Medical Center, Brooklyn, USA
    Cutis 74:16-21. 2004
    ..The authors review their prescribing practices and special considerations for women, African Americans, patients living in dry climates, adolescents, and Asian Americans...
  31. ncbi request reprint Azelaic acid gel 15%: clinical versatility in the treatment of rosacea
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, USA
    Cutis 78:6-19. 2006
    ..In a roundtable discussion, information leaders discussed the pathophysiology of rosacea and other issues of importance to successful rosacea management, such as skin care regimens, quality of life (QOL), and compliance...
  32. ncbi request reprint The use of moisturizers as an integral component of topical therapy for rosacea: clinical results based on the Assessment of Skin Characteristics Study
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, Nevada, USA
    Cutis 84:72-6. 2009
    ..Scores for severity and duration of stinging, burning, tingling, and itching were recorded in the morning and evening for 7 days. Cumulative symptom scores (CSSs) decreased on the right side of the face with facial moisturizer applied...
  33. ncbi request reprint Adjunctive skin care in the management of rosacea: cleansers, moisturizers, and photoprotectants
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, USA
    Cutis 75:17-21; discussion 33-6. 2005
    ..This review summarizes information regarding 3 classes of these products--cleansers, moisturizers, and photoprotectants--with emphasis on barrier function and skin irritation...
  34. ncbi request reprint Management of truncal acne vulgaris: current perspectives on treatment
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, USA
    Cutis 77:285-9. 2006
    ..This article discusses clinical challenges related to the management of truncal acne vulgaris, a system for rating disease severity, and recommendations regarding the use of topical and systemic therapies...
  35. ncbi request reprint Benzoyl peroxide cleansers for the treatment of acne vulgaris: status report on available data
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, Nevada, USA
    Cutis 82:336-42. 2008
    ..This article discusses available data on BPO cleanser formulations...
  36. ncbi request reprint Truncal acne vulgaris: the relative roles of topical and systemic antibiotic therapy
    James Q Del Rosso
    University of Nevada School of Medicine, Touro University College of Osteopathic Medicine, USA
    J Drugs Dermatol 6:148-51. 2007
    ..This trial was designed to capture observational experience reflective of treatment of patients with truncal acne in a private practice dermatology setting...
  37. ncbi request reprint Antibiotic use in acne vulgaris and rosacea: clinical considerations and resistance issues of significance to dermatologists
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, USA
    Cutis 82:5-12. 2008
    ....
  38. ncbi request reprint Evaluating the role of topical therapies in the management of rosacea: focus on combination sodium sulfacetamide and sulfur formulations
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, USA
    Cutis 73:29-33. 2004
    ..The sulfacetamide/sulfur cleansers serve as adjunctive therapy by providing additive effects to other topical and oral therapies for rosacea with favorable tolerability and cosmetic appeal...
  39. ncbi request reprint Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea
    Diane M Thiboutot
    Department of Dermatology, Pennsylvania State University College of Medicine, Hershey, PA, USA
    J Drugs Dermatol 7:541-6. 2008
    ..In order to test this hypothesis, an exploratory study was conducted...
  40. ncbi request reprint The treatment of rosacea
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, USA
    Cutis 73:34-6. 2004
    ..A lively discussion centered on treatment options for the various subtypes of rosacea ensued...
  41. ncbi request reprint Topical metronidazole combination therapy in the clinical management of rosacea
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, NV, USA
    J Drugs Dermatol 4:473-80. 2005
    ..In this paper, the results of observational experience evaluating topical metronidazole 0.75% gel used in combination with other topical rosacea therapies and/or subantimicrobial dose doxycycline are reported...
  42. ncbi request reprint Recently approved systemic therapies for acne vulgaris and rosacea
    James Q Del Rosso
    University of Nevada School of Medicine, Las Vegas, USA
    Cutis 80:113-20. 2007
    ..This article discusses the studies and clinical applications related to the use of these agents...
  43. ncbi request reprint Newer topical therapies for the treatment of acne vulgaris
    James Q Del Rosso
    Valley Hospitatal Medical Center, Las Vegas, Nevada, USA
    Cutis 80:400-10. 2007
    ..This article reviews applicable pharmacokinetic, efficacy, and safety data reported with both products...
  44. ncbi request reprint A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, Nevada, USA
    Cutis 85:15-24. 2010
    ..The efficacy of clindamycin in acne treatment has been shown to be sustained for more than 3 decades. It is likely that anti-inflammatory effects play an important role in the therapeutic activity of topical clindamycin...
  45. ncbi request reprint Medical treatment of rosacea with emphasis on topical therapies
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, Nevada, USA
    Expert Opin Pharmacother 5:5-13. 2004
    ..g., oral tetracycline derivative). Newer therapeutic choices primarily involve improved vehicle formulations, which demonstrate favourable skin tolerability and cosmetic elegance...
  46. ncbi request reprint The use of topical azelaic acid for common skin disorders other than inflammatory rosacea
    James Q Del Rosso
    University of Nevada School of Medicine, Las Vegas, USA
    Cutis 77:22-4. 2006
    ..This article reviews the therapeutic use of topical AzA for the treatment of common skin disorders other than the US Food and Drug Administration (FDA)-approved indications of acne vulgaris and inflammatory rosacea...
  47. ncbi request reprint Oral cephalosporin antibiotics: an overview of clinical pharmacology and dermatologic applications
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, USA
    Cutis 71:153-7. 2003
  48. ncbi request reprint New and emerging topical approaches for actinic keratoses
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, USA
    Cutis 72:273-6, 279. 2003
    ..This article reviews the efficacy and safety of topical diclofenac and topical imiquimod for the treatment of AKs...
  49. ncbi request reprint Cephalosporins in dermatology
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, USA
    Clin Dermatol 21:24-32. 2003
  50. ncbi request reprint The clinical impact of vehicle technology using a patented formulation of benzoyl peroxide 5%/clindamycin 1% gel: comparative assessments of skin tolerability and evaluation of combination use with a topical retinoid
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, NV, USA
    J Drugs Dermatol 5:160-4. 2006
    ..This article evaluates specific vehicle additives included in this gel formulation and explains their role in reducing irritation. Data from clinical trials utilizing this technology in acne management are also reviewed...
  51. ncbi request reprint A qualitative and quantitative assessment of the application and use of topical acne medication by patients
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, NV 89129, USA
    Cutis 76:109-13. 2005
  52. ncbi request reprint Impact of order of application of moisturizers on percutaneous absorption kinetics: evaluation of sequential application of moisturizer lotions and azelaic acid gel 15% using a human skin model
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, Nevada, USA
    Cutis 83:119-24. 2009
    ....
  53. ncbi request reprint Antibiotic resistance: overview and significance in dermatology
    James Q Del Rosso
    University of Nevada School of Medicine, Las Vegas, USA
    Cutis 75:12-8. 2005
    ..In some cases, resistance genes may be transferred among different bacterial species. A detailed review of resistance mechanisms is provided in this article...
  54. ncbi request reprint An update on newer topical therapies for actinic keratoses: advances and applications
    James Q Del Rosso
    Las Vegas Skin and Cancer Clinics, 4488 S Pecos Road, Las Vegas, Nevada 89121, USA
    J Drugs Dermatol 2:35-9. 2003
  55. ncbi request reprint Defining criteria used to evaluate response to treatment of acne vulgaris
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, USA
    Cutis 78:117-21. 2006
    ..Specific study outcomes, including those reported in more recent trials with topical adapalene, are utilized as illustrative examples...
  56. ncbi request reprint A status report on the use of subantimicrobial-dose doxycycline: a review of the biologic and antimicrobial effects of the tetracyclines
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, USA
    Cutis 74:118-22. 2004
  57. ncbi request reprint The role of the vehicle in combination acne therapy
    James Q Del Rosso
    University of Nevada School of Medicine, Las Vegas, USA
    Cutis 76:15-8. 2005
    ....
  58. ncbi request reprint Clinical significance of brand versus generic formulations: focus on oral minocycline
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, USA
    Cutis 77:153-6. 2006
    ..This article reviews available data on minocycline use for acne vulgaris and discusses a patented brand of minocycline versus generic formulations, including evaluations of pharmacologic activity and safety...
  59. ncbi request reprint Selection of therapy for acne vulgaris: balancing concerns about antibiotic resistance
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, USA
    Cutis 82:12-6. 2008
    ..Better efficacy has been noted with BPO-antibiotic combination therapy...
  60. ncbi request reprint Current modalities and new advances in the treatment of basal cell carcinoma
    Roger I Ceilley
    Department of Dermatology, University of Iowa School of Medicine, Iowa City, IA, USA
    Int J Dermatol 45:489-98. 2006
    ..This review will highlight the role of standard treatment modalities and introduce new advances in the treatment of BCC...
  61. ncbi request reprint The use of topical imiquimod for the treatment of actinic keratosis: a status report
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, USA
    Cutis 76:241-8. 2005
    ..Recent evidence suggests that many patients who effectively are cleared of AK lesions after topical imiquimod use remain free of lesions for several months to 2 years or develop a minimal number of new AK lesions...
  62. ncbi request reprint Anti-inflammatory activity of tetracyclines
    Guy Webster
    Department of Dermatology, Jefferson Medical College, 833 Chestnut Street, Philadelphia, PA 19107, USA
    Dermatol Clin 25:133-5, v. 2007
    ..The article also discusses the effectiveness of tetracyclines in treating such diseases as acne vulgaris, rosacea, bullous dermatoses, granulomatous disease, and livedo vasculitis...
  63. ncbi request reprint Updates & perspectives on management of common dermatologic disorders
    James Q Del Rosso
    University of Nevada School of Medicine, Touro University College of Osteopathic Medicine, Las Vegas, NV, USA
    J Drugs Dermatol 6:662-4. 2007
  64. ncbi request reprint The treatment of viral infections and nonmelanoma skin cancers
    James Q Del Rosso
    University of Nevada School of Medicine, Las Vegas, USA
    Cutis 79:29-35. 2007
    ....
  65. ncbi request reprint Tackling the anterior nares and other sites of colonization: implications for the dermatologist
    James Q Del Rosso
    University of Nevada School of Medicine, Las Vegas, USA
    Cutis 79:52-9. 2007
    ....
  66. ncbi request reprint Betamethasone valerate in foam vehicle is effective with both daily and twice a day dosing: a single-blind, open-label study in the treatment of scalp psoriasis
    S R Feldman
    Department of Dermatology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157 1071, USA
    J Cutan Med Surg 5:386-9. 2001
    ..Superior efficacy over a BMV lotion preparation has been demonstrated with twice-daily use. Even greater compliance would be expected if the drug is effective with once-daily application...
  67. ncbi request reprint Current approach to acne management: a community-based analysis
    James Q Del Rosso
    Valley Hospital Medical Center, Las Vegas, Nevada, USA
    Cutis 83:5-21; quiz 22-4. 2009
    ..Effective treatment of acne vulgaris can prevent adverse emotional sequelae and physical scarring. We hope that the information presented herein will help guide our colleagues in improving the care of patients with acne vulgaris...
  68. ncbi request reprint Retinoic acid receptors and topical acne therapy: establishing the link between gene expression and drug efficacy
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, USA
    Cutis 70:127-9. 2002
  69. ncbi request reprint Modern methods to treat superficial fungal disease
    James Q Del Rosso
    Department of Dermatology, University of Alabama at Birmingham, USA
    Cutis 79:6-29. 2007
  70. ncbi request reprint Oral trimethoprim/sulfamethoxazole in the treatment of acne vulgaris
    Sanjay Bhambri
    Valley Hospital Medical Center, Las Vegas, Nevada, USA
    Cutis 79:430-4. 2007
    ..TMP-SMX has been used off label in dermatology to treat various skin conditions, including acne vulgaris and other skin and soft tissue infections, especially those infections caused by methicillin-resistant Staphylococcus aureus...
  71. ncbi request reprint Laser and light-based therapies for acne vulgaris: a current guide based on available data
    Grace K Kim
    Mohave Skin and Cancer Clinics, Las Vegas, NV, USA
    J Drugs Dermatol 9:614-21. 2010
    ..These challenges drive research into non-pharmacologic approaches to AV treatment, including laser and light-based approaches...
  72. ncbi request reprint A status report on drug-associated acne and acneiform eruptions
    Saira B Momin
    Valley Hospital Medical Center, Las Vegas, NV, USA
    J Drugs Dermatol 9:627-36. 2010
    ..Additionally, in other cases of drug-associated acneiform eruptions, despite clinical similarity, histologic features are not consistent with acne vulgaris...
  73. ncbi request reprint Pathogenesis of acne vulgaris: recent advances
    Sanjay Bhambri
    Valley Hospital Medical Center, Las Vegas, NV 89106, USA
    J Drugs Dermatol 8:615-8. 2009
    ..Recent advances have been made in this area with the discovery of P. acnes interaction with Toll-like receptors (TLRs), vaccines targeting P. acnes or its components, antimicrobial peptides and the role of hormones...
  74. ncbi request reprint Topical retinoids in the management of acne: the best path to clear results
    James Q Del Rosso
    Cutis 74:2-3. 2004
  75. ncbi request reprint Benzoyl peroxide microsphere cream as monotherapy and combination treatment of acne
    Joseph Bikowski
    Ohio State University, Columbus, OH, USA
    J Drugs Dermatol 7:590-5. 2008
    ..This article presents a series of patients from 2 private dermatologic practices treated with a new BPO microsphere cream formulation both as monotherapy and in combination with other acne drugs...
  76. ncbi request reprint Update on rosacea pathogenesis and correlation with medical therapeutic agents
    James Q Del Rosso
    Department of Dermatology, University of Nevada School of Medicine, Las Vegas, USA
    Cutis 78:97-100. 2006
    ..This article updates current views on mechanisms potentially associated with rosacea. Although data is limited, correlation with therapies is reviewed...
  77. ncbi request reprint Systemic retinoid therapy: a status report on optimal use and safety of long-term therapy
    Alpesh Desai
    Heights Dermatology and Aesthetic Center, 2120 Ashland Street, Houston, TX 77008, USA
    Dermatol Clin 25:185-93, vi. 2007
    ....
  78. ncbi request reprint Acne and rosacea
    James Q Del Rosso
    J Drugs Dermatol 7:525. 2008
  79. ncbi request reprint Healthcare utilization and costs of patients with rosacea in an insured population
    Michael Romanowicz
    Managed Care and Professional Affairs, CollaGenex Pharmaceuticals, Inc, Newtown, PA 18940, USA
    J Drugs Dermatol 7:41-9. 2008
    ..S. However, there is little data in the literature on the healthcare utilization and costs of patients with rosacea in insured populations...